ClinicalTrials.gg
RecruitingNCT06185010TRAIN4BRAINUpdated Aug 6, 2024

Resistance Training to Individuals for Cognitive Impairment With Dementia

An interventional study of One Resistance Training Set (Single Session) and Three Resistance Training Sets (Single Session) in Mild Cognitive Impairment and Mild Dementia, sponsored by University of Beira Interior. Recruiting at 1 site in Portugal. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-06.

Sponsored by University of Beira Interior · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Cognitive Dysfunction with a site in Portugal — 13 open to participants now, 14 under way, 1 of them phase 3. Cognitive Dysfunction · Portugal.

Planned enrollment
14th of 33
80 · median 64
Started
2023
with 1 other
No phase
30 of 36
10 open now
Primary completion
2024-11
later than 0 of 13 live
Registered
21st of 36
by date
Lead sponsor
4 of 36
University of Beira Interior

Among the 36 studies in Cognitive Dysfunction with a site in Portugal, this one is the 14th largest by planned enrollment of the 33 interventional ones that give a count, is one of 2 that started in 2023, is one of 30 with no phase, reaches primary completion later than 0 of the 13 other live ones, and was the 21st registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

13 of the 36 studies in Cognitive Dysfunction with a site in Portugal are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 50 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Cognitive Dysfunction with a site in Portugal, or all of them as a file.
02

Study summary

This research project aims to analyze the effects of different resistance training volumes on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. First the investigators will analyze the effects of a single resistance training session (acute effects) with one and three sets on hemodynamic and physical performance in individuals with mild cognitive impairment. After, the investigators will analyze the effects of an 8-week resistance training program with one or three sets on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. The investigators hypothesize that a single resistance training session of one or three sets will increase the acute hemodynamic and physical performance stress in individuals with mild cognitive impairment, although with a higher magnitude in the session with three sets. Furthermore, we hypothesize that eight weeks of resistance training with one or three sets will induce similar improvements in cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.

Read the detailed description

Following specific inclusion and exclusion criteria (see Eligibility Criteria), participants will be recruited from residential care facilities or day centers. For the acute effects study (cross-over study), participants will randomly perform two resistance training sessions separated by one week of rest: i) one session with one set and ii) another session of three sets. The intensity of the exercises, number of repetitions, type and order of exercises, movement velocity, and rest time between exercises will be the same in both groups. Before, immediately after, and 72 hours after the sessions, a battery of tests will be applied to evaluate the changes in blood pressure, heart rate, tympanic temperature, medicine ball throw distance, five-repetition sit-to-stand time, and handgrip strength. Afterward, participants will be randomly assigned into a one-set or three-set group to perform an eight-week resistance training intervention. As for the acute effects study, the prescription of the other acute training variables will be the same for both groups. A control group (without any form of physical exercise), recruited at the beginning of the research project, will also be part of the study. Before and after the intervention, a battery of tests will be applied to determine the training program's impact on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.

03

Conditions studied

  • Mild Cognitive Impairment
  • Mild Dementia
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of mild cognitive impairment
  • SPPB score ≥ 3 points
  • Willingness to participate in the interventions and collaborate with the research team
  • Must be able to provide (oral or written)

Exclusion criteria

Exclusion criteria:

  • Severe dementia
  • Severe comorbidity that negatively influences participation in the intervention
  • Color blindness
  • Fractures in the last three months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    One Resistance Training Set (Single Session)

    The participants will perform one resistance training session with one set.

    Other: One Resistance Training Set (Single Session)

  • Experimental
    Three Resistance Training Sets (Single Session)

    The participants will perform one resistance training session with three sets.

    Other: Three Resistance Training Sets (Single Session)

  • Experimental
    One Resistance Training Set (8 Weeks)

    The participants will perform eight weeks of resistance training (two sessions per week, separated by 72 hours of rest) with one set.

    Other: One Resistance Training Set (8 Weeks)

  • Experimental
    Three Resistance Training Sets (8 Weeks)

    The participants will perform eight weeks of resistance training (two sessions per week, separated by 72 hours of rest) with three sets.

    Other: Three Resistance Training Sets (8 Weeks)

  • Experimental
    Control (8 Weeks)

    The participants will not perform any form of physical exercise during the intervention period of eight weeks.

    Other: Control (8 Weeks)

Interventions

  • OtherOne Resistance Training Set (Single Session)

    The participants will perform a resistance training session with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions at 55% 1RM in the chest press, iv) 1 set of 10 repetitions in the sit-to-stand exercise, v) 1 set of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.

  • OtherThree Resistance Training Sets (Single Session)

    The participants will perform a resistance training session with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions at 55% 1RM in the chest press, iv) 3 sets of 10 repetitions in the sit-to-stand exercise, v) 3 sets of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.

  • OtherOne Resistance Training Set (8 Weeks)

    The participants will perform eight weeks of resistance training with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions between 40-60% 1RM in the chest press, iv) 1 set of 6-12 repetitions in the sit-to-stand exercise, v) 1 set of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.

  • OtherThree Resistance Training Sets (8 Weeks)

    The participants will perform eight weeks of resistance training with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions between 40-60% 1RM in the chest press, iv) 3 sets of 6-12 repetitions in the sit-to-stand exercise, v) 3 sets of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.

  • OtherControl (8 Weeks)

    The participants in the control group will maintain their regular daily activities without performing any form of physical exercise.

06

What researchers measure

Primary outcomes

  1. Systolic blood pressure (SBP)

    In the cross-over study (acute effects), the SBP will be assessed through a blood pressure device.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  2. Handgrip strength (HGS)

    In the cross-over study (acute effects), the HGS will be assessed through an analogic dynamometer.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  3. Dementia Rating Scale-2 (DRS-2)

    In the eight-week study, the DRS-2 questionnaire will be applied to analyze the overall level of cognitive function through five subscales: attention, initiation/perseveration, construction, conceptualization, and memory.

    Time frame: Change from baseline to week 8

  4. Brain-Derived Neurotrophic Factor (BDNF)

    In the eight-week study, the BDNF protein levels will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  5. Short Physical Performance Battery (SPPB)

    In the eight-week study, the SPPB will determine the overall level of functional performance through three tests: balance (feet side by side, semi tandem, tandem), 4-meter walking, and 5-repetition sit-to-stand.

    Time frame: Change from baseline until week 8

Secondary outcomes

  1. Diastolic blood pressure (DBP)

    In the cross-over study (acute effects), the DBP will be assessed through a blood pressure device.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  2. Heart rate (HR)

    In the cross-over study (acute effects), the HR will be assessed through a blood pressure device.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  3. Tympanic temperature (TT)

    In the cross-over study (acute effects), the TT will be assessed through a tympanic thermometer.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  4. Five-repetition sit-to-stand (5STS)

    In the cross-over study (acute effects), the 5STS time will be recorded through a chronometer.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  5. 1-kg Medicine Ball Throw (MBT)

    In the cross-over study (acute effects), the MBT distance will be recorded with a tape measure.

    Time frame: Change from baseline to 0 minutes and 72 hours after the sessions

  6. Inflammatory markers

    In the eight-week study, inflammatory markers (IL-6, TNF-α, and IL-10) will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  7. Oxidative stress

    In the eight-week study, oxidative stress markers (carbonylated proteins) will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  8. Lipid Profile

    In the eight-week study, the lipid profile (LDL, HDL, total cholesterol, triglycerides) will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  9. HbA1c

    In the eight-week study, the HbA1c will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  10. Muscle Damage

    In the eight-week study, the muscle damage (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase) will be analyzed through specific blood testing kits.

    Time frame: Change from baseline to week 8

  11. One-repetition maximum (1RM)

    In the eight-week study, a progressive loading test until reaching the 1RM will be applied in the horizontal leg press and seated chest press machines.

    Time frame: Change from baseline to week 8

  12. Load-velocity profiles

    In the eight-week study, the load-velocity profiles will be analyzed using the velocity values (recorded with a linear velocity transducer) associated with the absolute loads used during the progressive loading tests in the horizontal leg press and seated chest press machines.

    Time frame: Change from baseline to week 8

  13. Ten-meters walking

    In the eight-week study, the 10-meter walking time will be measured through a chronometer.

    Time frame: Change from baseline to week 8

  14. 1-kg Medicine Ball Throw (MBT)

    In the eight-week study, the MBT distance will be recorded with a tape measure.

    Time frame: Change from baseline to week 8

  15. Handgrip strength (HGS)

    In the eight-week study, the HGS will be assessed through an analogic dynamometer.

    Time frame: Change from baseline to week 8

  16. 6-Minute Walk Test (6MWT)

    In the eight-week study, the 6MWT distance will be assessed by multiplying the number of total laps by the lap distance (e.g., 10 laps x 10 meters).

    Time frame: Change from baseline to week 8

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2023 (actual). Primary completion is estimated for Nov 2024, 11 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 11 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 14, 2023
First posted
Dec 29, 2023
StartActual
Dec 1, 2023
Primary completionEst.
Nov 30, 2024
CompletionEst.
Dec 31, 2024
Last update
Aug 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06185010
Lead sponsor
University of Beira Interior
Collaborators
Research Center in Sports Sciences, Health Sciences and Human Development
Responsible party
Nuno Miguel Pintassilgo da Silva Fonseca (Researcher, University of Beira Interior) — Principal investigator
First posted
Dec 29, 2023
Start date
Dec 1, 2023
Primary completion
Nov 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 6, 2024

Study contacts

Nuno Fonseca, Master's
Contact
nuno1977fonseca@gmail.com
918241354 ext. +351
Mário C Marques, PhD
principal investigator · University of Beira Interior
Dulce Esteves, PhD
principal investigator · University of Beira Interior
Mikel Izquierdo, PhD
principal investigator · Universidad Pública de Navarra

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion